KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesCash & Current InvestmentsCommon EquityConvertible DebtGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brookfield (BN) Cash & Equivalents (2016 - 2025)

Brookfield has reported Cash & Equivalents over the past 16 years, most recently at $12.4 billion for Q1 2025.

  • For Q1 2025, Cash & Equivalents changed N/A year-over-year to $12.4 billion; the TTM value through Mar 2025 reached $12.4 billion, changed N/A, while the annual FY2018 figure was $8.4 billion, 63.26% up from the prior year.
  • Cash & Equivalents for Q1 2025 was $12.4 billion at Brookfield, up from $11.2 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $12.4 billion in Q1 2025 and troughed at $2.5 billion in Q2 2021.
  • A 5-year average of $8.7 billion and a median of $11.3 billion in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 73.81% in 2021 and later rose 5.85% in 2022.
  • Year by year, Cash & Equivalents stood at $11.3 billion in 2021, then crashed by 76.73% to $2.6 billion in 2022, then surged by 357.84% to $12.1 billion in 2023, then fell by 6.93% to $11.2 billion in 2024, then grew by 10.56% to $12.4 billion in 2025.
  • Business Quant data shows Cash & Equivalents for BN at $12.4 billion in Q1 2025, $11.2 billion in Q2 2024, and $12.1 billion in Q3 2023.